IGFBP3 inhibits tumour growth and invasion of H1299 lung cancer cells and leads to improved survival in patients with lung cancer
A. Frille (Leipzig, Germany), H. Kuhn (Leipzig, Germany), M. Petersen (Leipzig, Germany), J. Meyer (Leipzig, Germany), L. Hofmann (Leipzig, Germany), A. Gläser (Leipzig, Germany), S. Taubenheim (Leipzig, Germany), S. Krämer (Leipzig, Germany), J. Broschewitz (Bremen, Germany), M. Von Laffert (Leipzig, Germany), H. Wirtz (Leipzig, Germany)
Source: International Congress 2022 – Biomarkers and beyond in lung cancer
Session: Biomarkers and beyond in lung cancer
Session type: Oral Presentation
Number: 1384
   
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Frille (Leipzig, Germany), H. Kuhn (Leipzig, Germany), M. Petersen (Leipzig, Germany), J. Meyer (Leipzig, Germany), L. Hofmann (Leipzig, Germany), A. Gläser (Leipzig, Germany), S. Taubenheim (Leipzig, Germany), S. Krämer (Leipzig, Germany), J. Broschewitz (Bremen, Germany), M. Von Laffert (Leipzig, Germany), H. Wirtz (Leipzig, Germany). IGFBP3 inhibits tumour growth and invasion of H1299 lung cancer cells and leads to improved survival in patients with lung cancer. 1384
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|